126 related articles for article (PubMed ID: 29554104)
41. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
42. IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation.
Dowling JP; Nikitin PA; Shen F; Shukla H; Finn JP; Patel N; Swider C; Bingaman-Steele JL; Nicolescu C; Sikorski EL; Greenawalt EJ; Morin MJ; Robinson MK; Lundgren K; Harman BC
MAbs; 2023; 15(1):2212673. PubMed ID: 37216961
[TBL] [Abstract][Full Text] [Related]
43. Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders.
Haghshenas MR; Zamir MR; Sadeghi M; Fattahi MJ; Mirshekari K; Ghaderi A
Eur Cytokine Netw; 2022 Sep; 33(3):54-69. PubMed ID: 37052152
[TBL] [Abstract][Full Text] [Related]
44. Neutrophil Extracellular Traps in Skin Diseases.
Ogawa Y; Muto Y; Kinoshita M; Shimada S; Kawamura T
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944704
[TBL] [Abstract][Full Text] [Related]
45. Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study.
Esmaeilzadeh A; Bahmaie N; Nouri E; Hajkazemi MJ; Zareh Rafie M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830435
[TBL] [Abstract][Full Text] [Related]
46. Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice.
Xue Y; Chen M; Chen Q; Huang T; Fan Q; Lin F; Ke J; Chen F
Virol J; 2021 Nov; 18(1):220. PubMed ID: 34775963
[TBL] [Abstract][Full Text] [Related]
47. IL-1 Family Antagonists in Mouse and Human Skin Inflammation.
Martin P; Goldstein JD; Mermoud L; Diaz-Barreiro A; Palmer G
Front Immunol; 2021; 12():652846. PubMed ID: 33796114
[TBL] [Abstract][Full Text] [Related]
48. Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice.
Watanabe S; Iwata Y; Fukushima H; Saito K; Tanaka Y; Hasegawa Y; Akiyama M; Sugiura K
Sci Rep; 2020 Nov; 10(1):20149. PubMed ID: 33214582
[TBL] [Abstract][Full Text] [Related]
49. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
50. IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis.
Goldstein JD; Bassoy EY; Caruso A; Palomo J; Rodriguez E; Lemeille S; Gabay C
Life Sci Alliance; 2020 Jun; 3(6):. PubMed ID: 32345660
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes.
Talabot-Ayer D; Mermoud L; Borowczyk J; Drukala J; Wolnicki M; Modarressi A; Boehncke WH; Brembilla N; Palmer G
PLoS One; 2019; 14(11):e0225782. PubMed ID: 31770407
[TBL] [Abstract][Full Text] [Related]
52. IL-38: A New Player in Inflammatory Autoimmune Disorders.
Xie L; Huang Z; Li H; Liu X; Zheng S; Su W
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387327
[TBL] [Abstract][Full Text] [Related]
53. Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation.
McEntee CP; Finlay CM; Lavelle EC
Front Immunol; 2019; 10():1266. PubMed ID: 31231388
[TBL] [Abstract][Full Text] [Related]
54. IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential.
Boutet MA; Nerviani A; Pitzalis C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871134
[TBL] [Abstract][Full Text] [Related]
55. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
[TBL] [Abstract][Full Text] [Related]
56. Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review.
Xu WD; Huang AF
Front Immunol; 2018; 9():1462. PubMed ID: 29988385
[TBL] [Abstract][Full Text] [Related]
57. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
58. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
59. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
